Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 7Unknown 3Terminated 2Not yet recruiting 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 3CNS 3Breast 3Gynecologic 2

Conditions

Pain, Postoperative 1Ovarian Neoplasms 1Advanced Ovarian Cancer 1

Interventions

Paclitaxel 24Carboplatin 18Bevacizumab 14Cisplatin 12pembrolizumab 7fluzoparib 7Drug Therapy 7Radiotherapy 6Magnetic Resonance Spectroscopy 6camrelizumab 5apatinib 5Topotecan 5Specimen Handling 5Injections 5liposomal doxorubicin 4lenvatinib 4famitinib 4Tirzepatide 4Platinum 4Observation 4Gemcitabine 4Brachytherapy 4toripalimab 3olaparib 3dostarlimab 3anlotinib 3Watchful Waiting 3Therapeutics 3Surveys and Questionnaires 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Saline Solution × Gynecologic × Clear all
NCT05794659 2023-07-20

Cornerstone4

Aston Sci. Inc.

Phase 2 Not yet recruiting
98 enrolled
Gynecologic

Advanced Ovarian Cancer

NCT05450055 2022-07-13

Intraperitoneal Lidocaine in Ovarian Cancer Surgery

Peking University Third Hospital

Phase NA Not yet recruiting
60 enrolled
Gynecologic

Ovarian Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡